Eli Lilly & Co.
LLY XNYS
$1157.49
+15.88 (+1.39%)
▲
15-min delayed
Open
$1147.15
High
$1177.07
Low
$1139.98
Volume
2.10M
Market Cap
$1.02T
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
TickerDaily Coverage
Pre-Market Stock Movers: Top 5 Biggest Gainers and Losers Before the Bell Today
Market News
Sarah Mitchell · Aug 28, 2026
Five major stocks are making outsized moves in pre-market trading Friday, August 28, 2026, ahead of...
Pre-Market Movers Today: Top 5 Stocks Making Biggest Moves Before the Bell (August 21, 2026)
Market News
Sarah Mitchell · Aug 21, 2026
Before the opening bell on Friday, August 21, 2026, five major stocks are making significant...
Stock Market Today, August 13, 2026: S&P 500 Closes Near Session Highs on Fed Pivot Signals
Market News
Sarah Mitchell · Aug 13, 2026
The stock market extended gains Thursday, August 13, 2026, as investors digested fresh inflation...
Healthcare Stocks This Week: XLV Gains 2.1% as UNH, LLY Lead Sector Rally (Aug 3–7, 2026)
Market News
David Brooks · Aug 7, 2026
The healthcare sector finished the week with solid momentum, as the Health Care Select Sector SPDR...
Stock Market This Week: Earnings Preview for August 3-7, 2026 — Disney, Eli Lilly, Caterpillar Lead Earnings Deluge
Market News
David Brooks · Jul 27, 2026
The stock market enters earnings season's heaviest week with mega-cap reports from Disney, Eli...
View All Coverage →
Get LLY Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Eli Lilly & Co..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.